1AI 16.7% 0.7¢ algorae pharmaceuticals limited

Well it maybe what's happened, but it's not entirely fair to say...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 17,046 Posts.
    lightbulb Created with Sketch. 2414
    Well it maybe what's happened, but it's not entirely fair to say so in that way. LCT was ready to commercialize Diabecell, but that was crippled by Otsuka who supplied the funds and controlled the direction of the project. The plan to commercialize NTcell was a good one and probably would have worked if they hadn't shot themselves in the foot with the trial design. They can't say the didn't know because I sent them the information and outlined the problems and concerns when the trial was being planned. But it's their company and their trial, but unfortunately we all paid the price.
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.